Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Chen

Showing results (571-580 of 633) with videos related to

Pageof 64
Sort By:
European Urology Focus|March 15, 2022
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell CarcinomasAngela Yoo, Cerise Tang, Mark Zucker, et al.
Endocrine Pathology|September 22, 2021
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical CarcinomasSounak Gupta, Helen Won, Kalyani Chadalavada, et al.
European Urology|February 20, 2022
Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing NephrectomyMaria I Carlo, Kyrollis Attalla, Yousef Mazaheri, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Cancer Cell|January 15, 2016
An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaA Ari Hakimi, Ed Reznik, Chung-Han Lee, et al.
Cell Metabolism|July 6, 2023
Immunometabolic coevolution defines unique microenvironmental niches in ccRCCCerise Tang, Amy X Xie, Eric Minwei Liu, et al.
The Journal of Cell Biology|October 12, 2011
Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potentialYing-Bei Chen, Miguel A Aon, Yi-Te Hsu, et al.
The American Journal of Surgical Pathology|May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available AntibodiesHenning Reis, Rene Serrette, Jennifer Posada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell CarcinomaMartin H Voss, Ana M Molina, Ying-Bei Chen, et al.
Human Pathology|March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinomaSumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
Pageof 64

Showing results (571-580 of 633) with videos related to

Sort By:
Pageof 64
European Urology Focus|March 15, 2022
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell CarcinomasAngela Yoo, Cerise Tang, Mark Zucker, et al.
Endocrine Pathology|September 22, 2021
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical CarcinomasSounak Gupta, Helen Won, Kalyani Chadalavada, et al.
European Urology|February 20, 2022
Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing NephrectomyMaria I Carlo, Kyrollis Attalla, Yousef Mazaheri, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Cancer Cell|January 15, 2016
An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaA Ari Hakimi, Ed Reznik, Chung-Han Lee, et al.
Cell Metabolism|July 6, 2023
Immunometabolic coevolution defines unique microenvironmental niches in ccRCCCerise Tang, Amy X Xie, Eric Minwei Liu, et al.
The Journal of Cell Biology|October 12, 2011
Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potentialYing-Bei Chen, Miguel A Aon, Yi-Te Hsu, et al.
The American Journal of Surgical Pathology|May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available AntibodiesHenning Reis, Rene Serrette, Jennifer Posada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell CarcinomaMartin H Voss, Ana M Molina, Ying-Bei Chen, et al.
Human Pathology|March 31, 2018
Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinomaSumit Isharwal, Hongying Huang, Gouri Nanjangud, et al.
Pageof 64